Effect of pidotimod combined with Yanhuning on children with refractory Mycoplasma pneumonia clinical symptoms and immune function / 中国生化药物杂志
Chinese Journal of Biochemical Pharmaceutics
;
(6): 246-248, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-612740
ABSTRACT
Objective To investigate the the curative effect of pidotimod combined with Yanhuning for children with refractory mycoplasma pneumonia(RMPP).Methods90 patients with RMPP from January 2013 to January 2015in shengzhou maternal and child health care hospital were divided into 3 groups, including Yanhuning group(A group), azithromycin combined with Yanhuning group(B group)and pidotimod combined with Yanhuning group(C group).And the total effective rate, the clinical symptoms, immune function parameters were analyzed.ResultsThe regulation of immune function in C group was more significant than that in A group and B group, the prognosis was better, and the repeated times and continuous time were decreased (P<0.05).ConclusionPidotimod combined with Yanhuning treatment of RMPP can regulate the immune function of children, improve clinical symptoms, it is worthy of popularization.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Diagnostic study
Language:
Chinese
Journal:
Chinese Journal of Biochemical Pharmaceutics
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS